Efficacy evaluation of treatment with diabetes commonly uses hemoglobin A1c (HbA1c); however, the level of this index does not allow for evaluation of treatment effects on insulin secretion or insulin resistance [2–4]. The gene discussed is INS; the disease is diabetes mellitus.